| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 32.668 | 41.033 | 42.676 | 37.571 | 32.116 | 25.620 | 27.511 | 58.588 | 24.206 | 18.552 |
| Total Income - EUR | 32.705 | 41.064 | 42.842 | 48.326 | 32.301 | 26.343 | 27.516 | 58.592 | 24.207 | 19.972 |
| Total Expenses - EUR | 38.661 | 50.419 | 43.526 | 39.438 | 32.188 | 27.219 | 25.436 | 49.967 | 28.971 | 25.172 |
| Gross Profit/Loss - EUR | -5.956 | -9.355 | -684 | 8.887 | 112 | -876 | 2.080 | 8.625 | -4.764 | -5.200 |
| Net Profit/Loss - EUR | -6.938 | -9.766 | -1.112 | 8.404 | -209 | -1.118 | 1.805 | 8.039 | -5.006 | -5.400 |
| Employees | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Biosystems Production S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 36 | 35 | 35 | -24 | 0 | 28 | 0 |
| Current Assets | 19.201 | 6.217 | 9.975 | 10.305 | 5.161 | 5.382 | 5.407 | 12.132 | 5.609 | 5.231 |
| Inventories | 3.144 | 2.512 | 5.674 | 2.757 | 927 | 2.473 | 2.236 | 1.926 | 1.407 | 1.799 |
| Receivables | 15.050 | 2.226 | 3.269 | 6.373 | 2.892 | 2.233 | 1.777 | 4.015 | 3.555 | 2.960 |
| Cash | 1.008 | 1.479 | 1.032 | 1.174 | 1.342 | 675 | 1.394 | 6.192 | 647 | 472 |
| Shareholders Funds | -9.871 | -19.536 | -20.318 | -11.541 | -11.527 | -12.426 | -10.346 | -2.339 | -7.339 | -12.698 |
| Social Capital | 427 | 423 | 416 | 408 | 400 | 393 | 384 | 385 | 384 | 382 |
| Debts | 29.145 | 25.871 | 30.347 | 21.984 | 16.742 | 17.850 | 15.731 | 14.595 | 12.980 | 17.928 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4329 - 4329" | |||||||||
| CAEN Financial Year |
4329
|
|||||||||
Comments - Biosystems Production S.r.l.